Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04241939
Other study ID # 19-0198
Secondary ID K12HD052023
Status Completed
Phase N/A
First received
Last updated
Start date February 14, 2020
Est. completion date September 14, 2020

Study information

Verified date January 2020
Source The University of Texas Medical Branch, Galveston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study tests the feasibility and acceptability of a numberless behavioral digital scale (BDS) intervention combined with motivational interviewing (MI) to affect lifestyle changes to promote weight loss in adolescents who are obese. Half of the participants will receive this intervention, while the other half will use a digital scale along with the standard adolescent weight loss program.


Description:

The proposed pilot project seeks to enhance motivation for lifestyle change in adolescents who are obese. It will test a novel intervention that combines modified MI-based counseling and BDS. We will test the feasibility of the intervention over a 12-week period, with 24-week follow-up compared to use of standard digital scale. All participants will undergo the standard adolescent weight loss program, which includes monthly clinic visits with dietary and physical activity counseling. The MI intervention will include modified MI, brief weekly telephone reinforcement, and use of a BDS. The BDS with its mobile app offers daily feedback through colors, daily missions to promote healthy habits, and weekly healthy tips from nutritionists. In addition to the primary outcome of feasibility (daily weighing) investigators will also explore the intervention's effect on motivation, psychological outcomes and various aspects of feasibility and acceptability.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date September 14, 2020
Est. primary completion date September 14, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria: - Age between 12 and 18 years - BMI greater than or equal to 95th percentile for age and sex group or BMI greater than or equal to 35 kg/m^2 - Participant (not parent) is able to read and understand English (app is in English) - Smartphone device with Wi-Fi and app capability - Willingness to be randomized to any condition Exclusion Criteria: Age 19 years or older - Developmental delay - Inability to provide informed consent - Any medical condition that, in the opinion of the PI, would place the participant at increased risk - Use of an investigational agent in the 30 days prior to signing informed consent - History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would , in the opinion of the PI, make it difficult for the participant to comply with study procedures or follow instructions - Females who are pregnant or lactating, by verbal report - Pre-existing conditions (i.e paralysis, heart failure, severe autism or mental retardation, psychosis, etc.) - Prisoners - Lack of transportation

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Numberless BDS
Participants perform daily weighing using a numberless BDS with feedback from app (color codes, challenges), in conjunction with modified motivational interviewing (clinic visits and weekly telephone calls), and the standard adolescent weight loss program.
Digital Scale
Participants perform daily weighing using a digital scale (number readout), in conjunction with standard adolescent weight loss program
Modified Motivational Interviewing
Modified motivational interviewing (clinic visits and weekly telephone calls), and the standard adolescent weight loss program.

Locations

Country Name City State
United States UTMB League City Texas
United States UTMB Webster Texas

Sponsors (3)

Lead Sponsor Collaborator
The University of Texas Medical Branch, Galveston Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of Modified MI and BDS Attendance at in-clinic visits, completion of weekly phone calls, and daily weighing based on BDS app data collected at 24 week assessment. 24 weeks
Primary Acceptability of Modified MI and BDS Number of participants in each group who are lost to follow-up 24 weeks
Secondary Anthropometrics Body Mass Index (BMI) 24 weeks
Secondary Bio-impedence measures Measures body fat (%) 24 weeks
Secondary Anxiety Self-reported anxiety on a scale from 0 (not at all) to 3 (severely) using the Beck Anxiety Inventory Change from 0 to 24 weeks
Secondary Depression Self-reported depression screening on a scale from 0 (not at all) to 3 (nearly every day) using the PHQ-9: Modified for Teens Change from 0 to 24 weeks
Secondary Bio-impedence measures Measures muscle mass (%) 24 weeks
Secondary Bio-impedence measures Measures visceral fat (%) 24 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2